Resources

Your selections:

Clear all

Show Filters

We found 282 resources that match your search.

HIV-1 Adenovirus Type 4-Vectored (A549 cells) Vaccines (Ad4-Env150KN and Ad4-Env145NFL)

Document Date:

HIV-1 Vaccines AdC6-HIVgp140, AdC7-HIVgp140, CH505TF/GLA-SE

Document Date:

How to Initiate the ClinicalTrials.gov Initial Registration Process Memorandum

Document Date:

HPTN - Expedited Reporting to DAIDS and DAERS Refresher

.zip files contains Presentation to HPTN/IMPAACT Annual Meeting on Expedited Reporting to DAIDS and DAERS refresher course Expedited reporting via DAERS - Case Study

Document Date:

HVTN - Expedited Reporting to DAIDS and DAERS Refresher

.zip file contains: Presentation to HVTN Annual Meeting on Expedited Reporting to DAIDS and DAERS refresher course; Expedited reporting via DAERS - Case Study

Document Date:

HxB2.WT.Core-C4b, Adjuvanted

Document Date:

Hydroxychloroquine Sulfate Package Insert

Document Date:

IBC RAC Guidance

Guidance and requirements for daids-supported research involving recombinant DNA.

Document Date:

ID93 + GLA Adjuvant Formulation Vaccine

Document Date:

IHV01

Document Date:

IMPAACT - Expedited Reporting to DAIDS and DAERS Refresher

.zip files contains: Safety training presentation on expedited reporting to DAIDS and a refresher on DAERS Case study handout Meeting for HPTN and IMPAACT networks was held June 2016.

Document Date:

IND Protocol Lists

List of IND protocols having CRF/Pharmacy records that will not be stored by DAIDS.

Document Date:

INO-6160 and INO-6172

Document Date:

Instructions for Authorization and Transfer of CRFs and Pharmacy Records to the DAIDS RSC

Instructions for the transfer of case report forms, (CRF) and pharmacy records to the DAIDS regulatory support center, (DAIDS RSC).

Document Date:

Instructions for Authorization and Transfer of CRFs and Pharmacy Records to the DAIDS RSC

Document Date:

Instructions Page for the DAIDS Protocol Specific Informed Consent Template 2/23/2016

Informed Consent documents are in the process of being updated to be compliant with the revised Common Rule.

Document Date:

Instructions Page for the DAIDS Protocol Specific Informed Consent Template 7/24/2013

DAIDS protocol specific informed consent template—general use.

Document Date:

Instructions Page for the DAIDS Sample Informed Consent Template - Stored samples and Associated Health Information for future Research Use

Informed Consent documents are in the process of being updated to be compliant with the revised Common Rule.

Document Date:

Intralipid

Document Date:

Isentress (raltegravir) Tablets, oral suspension, Package Insert

ISENTRESS is a human immunodeficiency virus integrase strand transfer inhibitor (HIV-1 INSTI) indicated: * In combination with other antiretroviral agents for the treatment of HIV-1 infection in patients 4 weeks of age and older (1). The use of other active agents with ISENTRESS is associated with…

Document Date:

Isoniazid Package Insert

Document Date:

Isoniazid Tablets, USP Package Insert

Isoniazid is an antibacterial available as 100 mg and 300 mg tablets for oral administration. Each tablet also contains as inactive ingredients: colloidal silicon dioxide, lactose monohydrate, pregelatinized starch (corn), povidone and stearic acid.

Document Date:

Lamivudine (Epivir)

The following side effects have also been associated with use of lamivudine: If you are infected with both Hepatitis B and HIV, you should be aware that your liver function tests may increase, and symptoms associated with hepatitis (an acute inflammation of the liver) may worsen if lamivudine is…

Document Date:

Ledipasvir/Sofosbuvir (Harvoni) Package Insert

HARVONI is a fixed-dose combination of ledipasvir, a hepatitis C virus (HCV) NS5A inhibitor, and sofosbuvir, an HCV nucleotide analog NS5B polymerase inhibitor, and is indicated for the treatment of chronic hepatitis C virus (HCV).

Document Date:

Levonorgestrel

Document Date: